Cite
HARVARD Citation
Rosenberg, J. et al. (2023). Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). Journal of clinical oncology. 41 (1), pp. 43-53. [Online].